Unspecified GLP-1
Sold by Joey Med · Injection, vial · every unspecified glp-1 record
What you actually pay
Per month
$199
| Medication · GLP-1 Core plan | $199 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| GLP-1 Core plan “GLP-1 Core — Injection A GLP-1 Core plan designed to support weight management, appetite control, and metabolic balance with weekly injections. Prescribed if clinically appropriate. Choose weeks/plan $279 / $199” | Per month$199 | Charged today$199 |
We earn nothing from this link. Joey Med has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| States | All 50 states |
|---|---|
| Prescriber | Both |
| Cancellation | “Refunds are initiated within 15 business days from the date of your Consultation outcome.” |
Not yet checked: pharmacy, membership and consult fee.
Recorded from joeymed.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — None of the three weight-loss plan pages ever name a specific active ingredient in their visible text — 'GLP-1 Core', 'GLP-1 Plus Core', and 'GLP-1 Plus Core High Dose' are all described only as generic 'GLP-1' with weekly injections, so all three are recorded as 'unspecified GLP-1' rather than assigned to semaglutide or tirzepatide. Notably the third plan's own URL slug is /weight-loss/tirz-hd (apparently short for 'tirzepatide high dose'), which strongly implies the drug, but per the brief's rule that a fact must appear in the printed page text, the URL alone was not treated as confirmation — the page body itself never says 'tirzepatide.' Each plan's pricing line reads 'Choose weeks/plan $[higher] / $[lower]' without stating whether the lower number is a monthly price, a one-time introductory price, or price-per-a-specific-number-of-weeks (the phrase 'Choose weeks/plan' suggests a week-count selector whose exact terms aren't resolved in static text) — recorded at term:1 as the closest reading but flagged as uncertain. Prescriber model is explicitly disclosed as either synchronous or asynchronous depending on the encounter, a rare direct answer. State coverage is asserted broadly as all 50 states in both the page title and body copy.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.